What is the correct way to administer Survanta?

Survanta is a medication specifically designed for the treatment of neonatal respiratory distress syndrome and is administered directly into the lungs to be effective. The correct method of administration is by inhalation, which allows the surfactant to reach the alveoli, the small air sacs in the lungs where gas exchange occurs. This method ensures that the medication can act quickly and efficiently within the pulmonary system, helping to reduce surface tension in the lungs and improve lung function in premature infants.

Other methods of administration, such as injection, IV, or oral routes, would not deliver the medication to the target site effectively or safely for this specific treatment. For instance, injecting the surfactant into a vein would bypass the lungs entirely, while oral administration would render the medication ineffective, as it would not reach the lungs at all. This specificity in the route of administration is crucial for achieving the desired therapeutic outcome in the management of respiratory distress syndrome in neonates.